RXi Pharmaceuticals Corporation (RXII) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 15 people. RXi Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 7.63 M. RXi Pharmaceuticals Corporation conducts business under Healthcare
sector and is part of Pharmaceutical Products
industry. This company has 2.37 M outstanding shares of which 1.76 M shares are at this time shorted by private and institutional investors with about 4.32 trading days to cover.
RXI PHARMACEUTICA currently holds about 5.42 M in cash with (8.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.29.
Check RXi Pharmaceuticals Probability Of Bankruptcy